Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.280 | 0.280 | 0.000 |
Shares | 99.720 | 99.720 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.417 | 21.195 |
Price to Book | 3.368 | 4.173 |
Price to Sales | 3.224 | 2.490 |
Price to Cash Flow | 14.034 | 17.334 |
Dividend Yield | 2.720 | 1.320 |
5 Years Earnings Growth | 15.150 | 13.721 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 6.97 | 91.99 | +0.07% | |
Roche Holding Participation | CH0012032048 | 6.95 | 251.50 | +0.04% | |
J&J | US4781601046 | 6.55 | 154.52 | -0.01% | |
Pfizer | US7170811035 | 6.39 | 25.77 | -1.53% | |
Merck&Co | US58933Y1055 | 6.21 | 101.62 | +0.45% | |
Eli Lilly | US5324571083 | 4.51 | 789.32 | +4.55% | |
AbbVie | US00287Y1091 | 4.15 | 181.14 | +2.30% | |
Chugai Pharmaceutical | JP3519400000 | 4.07 | 6,576.0 | +3.15% | |
Daiichi Sankyo | JP3475350009 | 3.83 | 4,642.0 | +2.02% | |
Vertex | US92532F1003 | 3.72 | 467.07 | +1.16% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson & Co Global Top 25 Brands | 713.69M | 8.06 | 5.52 | 11.64 | ||
Seligson Co Global Top 25 Brands Fu | 713.69M | 8.06 | 5.53 | 11.68 | ||
Seligson North American B | 534.76M | 26.69 | 13.09 | 14.29 | ||
Seligson & Co North American A | 534.76M | 26.70 | 13.09 | 14.31 | ||
FI4000283031 | 385.74M | 25.38 | 13.01 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review